Source: ScreenPro Security
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • ScreenPro’s (SCRN) wholly-owned operating subsidiary Concierge Medical Consultants has launched Prestige Medical Care to private clientele in Vancouver
  • Prestige’s healthcare program delivers a full-service concierge health management system through personalized medical and non-medical care
  • ScreenPro is a screening and medical technology company that provides turnkey screening solutions with its proprietary medical alerting software
  • ScreenPro Security Inc. (SCRN) is trading steady at C$0.03 per share at 10:35 am ET

ScreenPro’s (SCRN) operating subsidiary Concierge Medical Consultants has launched Prestige Medical Care (PMC) to private clientele in Vancouver.

Prestige’s healthcare program delivers a full-service concierge health management system through personalized medical and non-medical care. It offers 24/7 medical care with house calls, virtual appointments, wellness visits, unlimited and same-day clinic visits, and prescriptions.

Lena Kozovski, Chief Executive Officer of Concierge, stated that with private health care on the rise as the public sector faces demand, this team of board-certified physicians and registered nurses are prepared to service the community.

“Management is confident that continued growth is expected for our medical division and look forward to expanding Concierge to help improve the lives of our community.”

The B.C. Medical Journal recently reported that 17.7 per cent of people in the province lacked a health care provider due to staff shortages.

ScreenPro is a screening and medical technology company that provides turnkey screening solutions with its proprietary medical alerting software.

ScreenPro Security Inc. (SCRN) is trading steady at C$0.03 per share at 10:35 am ET.

More From The Market Herald
Small Pharma - CEO, George Tziras.

" Small Pharma (TSXV:DMT) announces NCIB

Small Pharma (DMT) has received TSXV approval for a normal course issuer bid.
Spectral Medical Inc. - CMO, Dr. John Kellum

" Spectral (TSX:EDT) gets FDA approval for Tigris trial

Spectral Medical (EDT) announced that the U.S. Food and Drug Administration (FDA) has approved ten new clinical trial sites for the Tigris trial.

" Diagnos (TSXV:ADK) receives approval for its AI enabled Pathology Detection Systems

Diagnos (ADK) has received approval from the Costa Rican regulatory agency for its Artificial Intelligence (AI) enabled Pathology Detection Systems.

" BioHarvest (CSE:BHSC) launches first major U.S marketing campaign

BioHarvest Sciences (BHSC) has announced the first multimedia campaign for VINIA in the USA, Phase 1.